Remove Data Remove Hash Remove Safety Remove Terpenes
article thumbnail

What is weed’s new CRC tech, and can it hurt you?

SpeedWeed

The rise of new ways of making hash, as well as cleaning up dirty hash, mean that the old tricks don’t always work. Safety data is limited, and testing for CRC contamination is missing—even in legalization states. CRC changes a low-grade hash oil’s color from almost black, or dark brown, to light gold, or even white.

Hash 52
article thumbnail

Hemp wick vs butane lighter: What’s the best way to smoke weed?

SpeedWeed

Wurzer agreed, saying “I don’t have a ton of good data on this.”. Just like a low-temperature hit from a hash bubbler burns less terpenes and maxes out a dab’s flavor, hemp wick uses a gentler heat for a more flavorful smoke. For convenience and fire safety, flick that BIC. Hippie wick health. Is it snack time yet?

Hemp 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to use a dab pen

The Cannigma

bubble hash Budder Crumble hash live resin Kief rosin shatter sugar wax. Because you can control the temperature more on a dab pen, you’re able to preserve more terpenes in your hits. Most terpenes have significantly lower boiling points than cannabinoids and will be heated off quickly in a dab rig. How to hit a dab pen.

article thumbnail

What is phytol and is it safe to vape?

SpeedWeed

The document in question was a 2020 safety study of the vape cartridge additive phytol. The data contained in that report has rocked the cannabis vaping world. Phytol is a terpene that’s sometimes used to add flavor to vape cartridges, usually by adding it to a mix of cannabis oil and the common thinning agent propylene glycol.

Vaping 52
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Data collection.